Progranulin and GPNMB: Interactions in Endo-lysosome Function and Inflammation in Neurodegenerative Disease

Overview

Journal J Neuroinflammation

Publisher Biomed Central

Date 2023 Dec 1

PMID 38037070

Authors

Drew A Gillett

Rebecca L Wallings

Oihane Uriarte Huarte

Malu Gamez Tansey

Affiliations

Soon will be listed here.

Abstract

Background: Alterations in progranulin (PGRN) expression are associated with multiple neurodegenerative diseases (NDs), including frontotemporal dementia (FTD), Alzheimer's disease (AD), Parkinson's disease (PD), and lysosomal storage disorders (LSDs). Recently, the loss of PGRN was shown to result in endo-lysosomal system dysfunction and an age-dependent increase in the expression of another protein associated with NDs, glycoprotein non-metastatic B (GPNMB).

Main Body: It is unclear what role GPNMB plays in the context of PGRN insufficiency and how they interact and contribute to the development or progression of NDs. This review focuses on the interplay between these two critical proteins within the context of endo-lysosomal health, immune function, and inflammation in their contribution to NDs.

Short Conclusion: PGRN and GPNMB are interrelated proteins that regulate disease-relevant processes and may have value as therapeutic targets to delay disease progression or extend therapeutic windows.

Citing Articles

Neuroinflammation and glycosylation-related cerebrospinal fluid proteins for predicting functional decline in amyotrophic lateral sclerosis: a proteomic study.

Nakamura K, Fujita K, Suzuki M, Kunugi A, Hirozane Y, Kunikata T Front Neurol. 2024; 15:1418320.

PMID: 39624674 PMC: 11608993. DOI: 10.3389/fneur.2024.1418320.

Analyzing immune cell infiltrates in skeletal muscle of infantile-onset Pompe disease using bioinformatics and machine learning.

Zhang J, Lin X, Yin L, Song Y, Chen X, Zhu Y Sci Rep. 2024; 14(1):27485.

PMID: 39523364 PMC: 11551188. DOI: 10.1038/s41598-024-78634-6.

References

Lui H, Zhang J, Makinson S, Cahill M, Kelley K, Huang H . Progranulin Deficiency Promotes Circuit-Specific Synaptic Pruning by Microglia via Complement Activation. Cell. 2016; 165(4):921-35. PMC: 4860138. DOI: 10.1016/j.cell.2016.04.001. View

Xu H, Tan L, Wan Y, Tan M, Zhang W, Zheng Z . PGRN Is Associated with Late-Onset Alzheimer's Disease: a Case-Control Replication Study and Meta-analysis. Mol Neurobiol. 2016; 54(2):1187-1195. DOI: 10.1007/s12035-016-9698-4. View

Hartman M, Czyz M . MITF in melanoma: mechanisms behind its expression and activity. Cell Mol Life Sci. 2014; 72(7):1249-60. PMC: 4363485. DOI: 10.1007/s00018-014-1791-0. View

Suda M, Shimizu I, Katsuumi G, Yoshida Y, Hayashi Y, Ikegami R . Senolytic vaccination improves normal and pathological age-related phenotypes and increases lifespan in progeroid mice. Nat Aging. 2023; 1(12):1117-1126. DOI: 10.1038/s43587-021-00151-2. View

Ward M, Taubes A, Chen R, Miller B, Sephton C, Gelfand J . Early retinal neurodegeneration and impaired Ran-mediated nuclear import of TDP-43 in progranulin-deficient FTLD. J Exp Med. 2014; 211(10):1937-45. PMC: 4172214. DOI: 10.1084/jem.20140214. View

Almeida M, Macario M, Ramos L, Baldeiras I, Ribeiro M, Santana I . Portuguese family with the co-occurrence of frontotemporal lobar degeneration and neuronal ceroid lipofuscinosis phenotypes due to progranulin gene mutation. Neurobiol Aging. 2016; 41:200.e1-200.e5. DOI: 10.1016/j.neurobiolaging.2016.02.019. View

Mao Q, Zheng X, Gefen T, Rogalski E, Spencer C, Rademakers R . FTLD-TDP With and Without GRN Mutations Cause Different Patterns of CA1 Pathology. J Neuropathol Exp Neurol. 2019; 78(9):844-853. PMC: 7967835. DOI: 10.1093/jnen/nlz059. View

Ferretti M, Iulita M, Cavedo E, Chiesa P, Dimech A, Chadha A . Sex differences in Alzheimer disease - the gateway to precision medicine. Nat Rev Neurol. 2018; 14(8):457-469. DOI: 10.1038/s41582-018-0032-9. View

Weterman M, Ajubi N, van Dinter I, Degen W, van Muijen G, Ruitter D . nmb, a novel gene, is expressed in low-metastatic human melanoma cell lines and xenografts. Int J Cancer. 1995; 60(1):73-81. DOI: 10.1002/ijc.2910600111. View

10.

Holler C, Taylor G, Deng Q, Kukar T . Intracellular Proteolysis of Progranulin Generates Stable, Lysosomal Granulins that Are Haploinsufficient in Patients with Frontotemporal Dementia Caused by Mutations. eNeuro. 2017; 4(4). PMC: 5562298. DOI: 10.1523/ENEURO.0100-17.2017. View

11.

Ramani V, Chung J, Ariizumi K, Cruz Jr P . Soluble DC-HIL/Gpnmb Modulates T-Lymphocyte Extravasation to Inflamed Skin. J Invest Dermatol. 2021; 142(5):1372-1380.e5. DOI: 10.1016/j.jid.2021.10.004. View

12.

Arechavaleta-Velasco F, Perez-Juarez C, Gerton G, Diaz-Cueto L . Progranulin and its biological effects in cancer. Med Oncol. 2017; 34(12):194. PMC: 5810362. DOI: 10.1007/s12032-017-1054-7. View

13.

Chang M, Srinivasan K, Friedman B, Suto E, Modrusan Z, Lee W . Progranulin deficiency causes impairment of autophagy and TDP-43 accumulation. J Exp Med. 2017; 214(9):2611-2628. PMC: 5584112. DOI: 10.1084/jem.20160999. View

14.

Minami S, Min S, Krabbe G, Wang C, Zhou Y, Asgarov R . Progranulin protects against amyloid β deposition and toxicity in Alzheimer's disease mouse models. Nat Med. 2014; 20(10):1157-64. PMC: 4196723. DOI: 10.1038/nm.3672. View

15.

Smith D, Aggarwal G, Niehoff M, Jones S, Banerjee S, Farr S . Biochemical, Biomarker, and Behavioral Characterization of the Grn Mouse Model of Frontotemporal Dementia. Mol Neurobiol. 2024; 61(11):9708-9722. PMC: 11496013. DOI: 10.1007/s12035-024-04190-9. View

16.

Van Kampen J, Baranowski D, Kay D . Progranulin gene delivery protects dopaminergic neurons in a mouse model of Parkinson's disease. PLoS One. 2014; 9(5):e97032. PMC: 4013129. DOI: 10.1371/journal.pone.0097032. View

17.

Tanaka Y, Suzuki G, Matsuwaki T, Hosokawa M, Serrano G, Beach T . Progranulin regulates lysosomal function and biogenesis through acidification of lysosomes. Hum Mol Genet. 2017; 26(5):969-988. DOI: 10.1093/hmg/ddx011. View

18.

Mendsaikhan A, Tooyama I, Walker D . Microglial Progranulin: Involvement in Alzheimer's Disease and Neurodegenerative Diseases. Cells. 2019; 8(3). PMC: 6468562. DOI: 10.3390/cells8030230. View

19.

Puoti G, Lerza M, Ferretti M, Bugiani O, Tagliavini F, Rossi G . A mutation in the 5'-UTR of GRN gene associated with frontotemporal lobar degeneration: phenotypic variability and possible pathogenetic mechanisms. J Alzheimers Dis. 2014; 42(3):939-47. DOI: 10.3233/JAD-140717. View

20.

Kayasuga Y, Chiba S, Suzuki M, Kikusui T, Matsuwaki T, Yamanouchi K . Alteration of behavioural phenotype in mice by targeted disruption of the progranulin gene. Behav Brain Res. 2007; 185(2):110-8. DOI: 10.1016/j.bbr.2007.07.020. View